Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

Yes. The current share price is hard to swallow, unless you're actively buying to hold, but truth be told is the usual suspects (Mako, otc, Rosen) are most to blame for inflicting reputational damages. Otherwise, there's zero to indicate that the four midphase phase 2 trials are in peril, rather, management's indications show progress.

Go figure.

At some point, she'll run like Forrest Gump.

I believe it will start on whenever the first positive interim data is revealed, and I continue to believe that's in March based on company releases.

Stay the course in the face of muck